Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doron Lipson

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Nature|July 31, 2010
New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanismPhilipp Kapranov, Fatih Ozsolak, Sang Woo Kim, et al.
Genome Research|July 19, 2011
Single-step capture and sequencing of natural DNA for detection of BRCA1 mutationsJohn F Thompson, Jeffrey G Reifenberger, Eldar Giladi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2004
Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNAMichael T Barrett, Alicia Scheffer, Amir Ben-Dor, et al.
Cancer Discovery|May 31, 2014
Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusionsChristine M Lovly, Abha Gupta, Doron Lipson, et al.
Journal of Clinical Pathology|October 27, 2015
Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targetsHwajeong Lee, Kai Wang, Adrienne Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2015
Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing ApproachesAlexander Drilon, Lu Wang, Maria E Arcila, et al.
The Oncologist|December 7, 2014
Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of originJuliann Chmielecki, Jeffrey S Ross, Kai Wang, et al.
Plos Computational Biology|February 8, 2018
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normalJames X Sun, Yuting He, Eric Sanford, et al.
Plos One|February 6, 2013
Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataMiriam Ragle Aure, Israel Steinfeld, Lars Oliver Baumbusch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapySiraj M Ali, R Katherine Alpaugh, Sean R Downing, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Nature|July 31, 2010
New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanismPhilipp Kapranov, Fatih Ozsolak, Sang Woo Kim, et al.
Genome Research|July 19, 2011
Single-step capture and sequencing of natural DNA for detection of BRCA1 mutationsJohn F Thompson, Jeffrey G Reifenberger, Eldar Giladi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2004
Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNAMichael T Barrett, Alicia Scheffer, Amir Ben-Dor, et al.
Cancer Discovery|May 31, 2014
Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusionsChristine M Lovly, Abha Gupta, Doron Lipson, et al.
Journal of Clinical Pathology|October 27, 2015
Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targetsHwajeong Lee, Kai Wang, Adrienne Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2015
Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing ApproachesAlexander Drilon, Lu Wang, Maria E Arcila, et al.
The Oncologist|December 7, 2014
Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of originJuliann Chmielecki, Jeffrey S Ross, Kai Wang, et al.
Plos Computational Biology|February 8, 2018
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normalJames X Sun, Yuting He, Eric Sanford, et al.
Plos One|February 6, 2013
Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataMiriam Ragle Aure, Israel Steinfeld, Lars Oliver Baumbusch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapySiraj M Ali, R Katherine Alpaugh, Sean R Downing, et al.
Pageof 10